A detailed history of Td Waterhouse Canada Inc. transactions in Pro Mis Neurosciences Inc. stock. As of the latest transaction made, Td Waterhouse Canada Inc. holds 133 shares of PMN stock, worth $152. This represents 0.0% of its overall portfolio holdings.

Number of Shares
133
Holding current value
$152
% of portfolio
0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 02, 2024

BUY
$1.5 - $2.49 $199 - $331
133 New
133 $362,000
Q1 2024

May 10, 2024

SELL
$1.28 - $2.81 $190 - $418
-149 Closed
0 $0
Q3 2022

Nov 13, 2023

BUY
$4.99 - $9.25 $743 - $1,378
149 New
149 $1.21 Million

Others Institutions Holding PMN

About ProMIS Neurosciences Inc.


  • Ticker PMN
  • Exchange OTC
  • Description
  • ProMIS Neurosciences, Inc. discovers and develops precision medicine solutions for the treatment of neurodegenerative diseases, primarily Alzheimer's disease (AD), amyotrophic lateral sclerosis (ALS), and multiple system atrophy (MSA) in Canada. The company's proprietary discovery platform comprises ProMIS and Collective Coordinates algorithms t...
More about PMN
Track This Portfolio

Track Td Waterhouse Canada Inc. Portfolio

Follow Td Waterhouse Canada Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Td Waterhouse Canada Inc., based on Form 13F filings with the SEC.

News

Stay updated on Td Waterhouse Canada Inc. with notifications on news.